NKGen Biotech, Inc. (NKGN)
NASDAQ: NKGN · Real-Time Price · USD
0.783
+0.019 (2.43%)
At close: Sep 6, 2024, 4:00 PM
0.789
+0.006 (0.77%)
After-hours: Sep 6, 2024, 4:25 PM EDT
NKGen Biotech Market Cap
NKGen Biotech has a market cap or net worth of $20.17 million as of September 6, 2024. Its market cap has decreased by -91.12% in one year.
Market Cap
20.17M
Enterprise Value
42.35M
1-Year Change
-91.12%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since May 21, 2021, NKGen Biotech's market cap has decreased from $186.20M to $20.17M, a decrease of -89.17%. That is a compound annual growth rate of -49.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 6, 2024 | 19.50M | -67.61% |
| Dec 29, 2023 | 60.20M | -71.79% |
| Dec 30, 2022 | 213.40M | 2.65% |
| Dec 31, 2021 | 207.90M | 11.65% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Athira Pharma | 20.81M |
| MEI Pharma | 20.65M |
| Brainstorm Cell Therapeutics | 20.53M |
| NeurAxis | 20.18M |
| SeaStar Medical Holding | 20.18M |
| Inspira Technologies Oxy B.H.N. | 20.08M |
| NanoViricides | 19.97M |
| TherapeuticsMD | 19.95M |